In the past few years, case-control studies of common diseases have shifted their focus from single genes to whole exomes. New sequencing technologies now routinely detect hundreds of thousands of sequence variants in a single study, many of which are rare or even novel. The limitation of classical single-marker association analysis for rare variants has been a challenge in such studies. A new generation of statistical methods for case-control association studies has been developed to meet this challenge. A common approach to association analysis of rare variants is the burden-style collapsing methods to combine rare variant data within individuals across or within genes. Here, we propose a new hybrid likelihood model that combines a burden...
Previously described methods for the combined analysis of common and rare variants have disadvantage...
Complex human diseases are a major challenge for biological research. The goal of my research is to ...
Sequencing and exome-chip technologies have motivated development of novel statistical tests to iden...
In the past few years, case-control studies of common diseases have shifted their focus from single ...
Biological and empirical evidence suggests that rare variants account for a large proportion of the ...
Biological and empirical evidence suggests that rare variants account for a large proportion of the ...
Deep sequencing will soon generate comprehensive sequence information in large disease samples. Alth...
Sequencing studies are increasingly being conducted to identify rare variants associated with comple...
Sequencing studies are increasingly being conducted to identify rare variants associated with comple...
Recently more and more evidence suggest that rare variants with much lower minor allele frequencies ...
Despite the success of genome-wide association studies (GWASs) in detecting common variants (minor a...
Despite the success of genome-wide association studies (GWASs) in detecting common variants (minor a...
Although whole-genome association studies using tagSNPs are a powerful approach for detecting common...
Case-control genetic sequencing studies are increasingly being conducted to identify rare variants a...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Previously described methods for the combined analysis of common and rare variants have disadvantage...
Complex human diseases are a major challenge for biological research. The goal of my research is to ...
Sequencing and exome-chip technologies have motivated development of novel statistical tests to iden...
In the past few years, case-control studies of common diseases have shifted their focus from single ...
Biological and empirical evidence suggests that rare variants account for a large proportion of the ...
Biological and empirical evidence suggests that rare variants account for a large proportion of the ...
Deep sequencing will soon generate comprehensive sequence information in large disease samples. Alth...
Sequencing studies are increasingly being conducted to identify rare variants associated with comple...
Sequencing studies are increasingly being conducted to identify rare variants associated with comple...
Recently more and more evidence suggest that rare variants with much lower minor allele frequencies ...
Despite the success of genome-wide association studies (GWASs) in detecting common variants (minor a...
Despite the success of genome-wide association studies (GWASs) in detecting common variants (minor a...
Although whole-genome association studies using tagSNPs are a powerful approach for detecting common...
Case-control genetic sequencing studies are increasingly being conducted to identify rare variants a...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Previously described methods for the combined analysis of common and rare variants have disadvantage...
Complex human diseases are a major challenge for biological research. The goal of my research is to ...
Sequencing and exome-chip technologies have motivated development of novel statistical tests to iden...